We are live on ! Find out more
GNPX icon

Genprex
GNPX

20 hedge funds and large institutions have $10.8M invested in Genprex in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

173% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $549K

10% more capital invested

Capital invested by funds: $9.78M → $10.8M (+$982K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

20% less funds holding

Funds holding: 25 → 20 (-5)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

63% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 8

Holders
20
Holders Change
-5
Holders Change %
-20%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
8
Calls
$1.5M
Puts
$549K
Net Calls
+$949K
Net Calls Change
+$821K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$195K
2
Charles Schwab
Charles Schwab
California
+$97.5K
3
Citadel Advisors
Citadel Advisors
Florida
+$97.5K
4
Group One Trading
Group One Trading
Illinois
+$97.5K
5
State Street
State Street
Massachusetts
+$97.5K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$1.85M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.18M
3
AFM
Anson Funds Management
Texas
-$575K
4
Millennium Management
Millennium Management
New York
-$488K
5
GCP
GSA Capital Partners
United Kingdom
-$390K
Name Holding Trade Value Shares
Change 		Change in
Stake
HIP
26
HUB Investment Partners
Texas
$36K – – –
NAS
27
Nicolet Advisory Services
Wisconsin
$31K – – –
SFI
28
Susquehanna Fundamental Investments
Pennsylvania
$29K – – –
Jane Street
29
Jane Street
New York
$28K – – –
HighTower Advisors
30
HighTower Advisors
Illinois
$25K – – –
Two Sigma Advisers
31
Two Sigma Advisers
New York
$25K – – –
FIM
32
Freedom Investment Management
Connecticut
$23K – – –
MAM
33
Meeder Asset Management
Ohio
$23K – – –
Osaic Holdings
34
Osaic Holdings
Arizona
$19K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$18K – – –
Barclays
36
Barclays
United Kingdom
$13K – – –
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$7K – – –
Fidelity Investments
38
Fidelity Investments
Massachusetts
$5K – – –
Citigroup
39
Citigroup
New York
$4K – – –
Wells Fargo
40
Wells Fargo
California
$4K – – –
Bank of America
41
Bank of America
North Carolina
$2K – – –
HNWAG
42
High Net Worth Advisory Group
Florida
$2K – – –
National Bank of Canada
43
National Bank of Canada
Quebec, Canada
$2K – – –
BC
44
Burleson & Co
California
$1K – – –
TWA
45
TCI Wealth Advisors
Arizona
$1K – – –
APA
46
American Portfolios Advisors
New York
$452 – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$165 – – –
Renaissance Technologies
48
Renaissance Technologies
New York
– -$1.18M -21 Closed
AFM
49
Anson Funds Management
Texas
– -$575K -10 Closed
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
– -$164K -3 Closed
1
2
3

GNPX Hedge Fund Activity: Q1 2022 in Review

20 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2022, worth a combined $10.8M — up 10% from $9.78M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of GNPX and 3 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Goldman Sachs, adding an estimated $195K. The largest seller was Morgan Stanley, cutting an estimated $1.85M.

  • 20 institutional investors held Genprex (GNPX) as of Q1 2022, down from 25 in Q4 2021.
  • Funds reported $10.8M of Genprex stock for Q1 2022, up 10% quarter-over-quarter.
  • 3 funds opened new Genprex positions in Q1 2022 and 8 closed out, a net change of -5 holders.
  • The largest Genprex buyer in Q1 2022 was Goldman Sachs, an estimated $195K added.
  • The largest Genprex seller in Q1 2022 was Morgan Stanley, an estimated $1.85M sold.

Based on aggregated 13F filings for Q1 2022.